688658 悦康药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.7844.8788.47214.53318.810
总资产报酬率 ROA (%)3.5203.1015.7129.7529.909
投入资产回报率 ROIC (%)4.7314.1527.54613.01211.001

边际利润分析
销售毛利率 (%)60.37862.67164.64569.24266.015
营业利润率 (%)8.5225.5237.88112.82411.343
息税前利润/营业总收入 (%)8.4175.0766.97612.00612.323
净利润/营业总收入 (%)6.9594.4687.46210.95010.224

收益指标分析
经营活动净收益/利润总额(%)105.419105.69099.087103.01992.327
价值变动净收益/利润总额(%)0.000-0.4511.1380.6410.000
营业外收支净额/利润总额(%)-2.699-3.800-2.407-1.2000.603

偿债能力分析
流动比率 (X)1.9441.6032.0542.4172.188
速动比率 (X)1.5191.2621.6652.0411.835
资产负债率 (%)38.83939.13933.47431.42634.288
带息债务/全部投入资本 (%)17.14813.63010.9355.554--
股东权益/带息债务 (%)467.427612.764792.2251,651.120833.064
股东权益/负债合计 (%)157.116155.074198.333218.025191.380
利息保障倍数 (X)71.229-20.734-9.695-18.02913.512

营运能力分析
应收账款周转天数 (天)76.89491.00781.03250.0780.000
存货周转天数 (天)168.214168.463153.642148.3640.000